Ravi Pratap Barnwal

University of the Punjab, Panjab University

Papers

Total Citations

H-Index

About

Ravi Pratap Barnwal is a pharmaceutical scientist whose research focuses on the transformative potential of nanotechnology in drug delivery and cancer therapy. His work bridges fundamental pharmaceutical science with cutting-edge nanomedicine, particularly exploring how size reduction at the nanoscale can revolutionize drug formulation. His most cited paper, "A Review on Status of Nanotechnology in Pharmaceutical Sciences" (2019, 11 citations), establishes the foundational principle that nanoparticle engineering enhances drug stability, reduces toxicity, and improves bioavailability—critical advances for modern pharmaceutical development. Building on this foundation, his more recent work "A Path of Novelty from Nanoparticles to Nanobots: Theragnostic Approach for Targeting Cancer Therapy" (2023, 6 citations) addresses one of medicine's most persistent challenges: cancer. This paper articulates how nanotechnology has overcome the inherent limitations of conventional cancer treatments by enabling theragnostic platforms that simultaneously diagnose and treat malignancies. Barnwal's research trajectory demonstrates a clear progression from fundamental nanopharmaceutical principles to targeted therapeutic applications, positioning him as a researcher contributing to the evolution of precision medicine through nanoscale innovation.